Neoadjuvant chemoradiation for patients with advanced oesophageal cancer - which response grading system best impacts prognostic discrimination?
Published inHistopathology, vol. 74, no. 5, p. 731-743
Publication date2019
Abstract
Keywords
- Adenocarcinoma
- Neoadjuvant chemoradiation
- Oesophageal cancer
- Regression grading
- Squamous
- Cell carcinoma
- Adenocarcinoma/mortality/pathology/surgery/therapy
- Adult
- Aged
- Aged, 80 and over
- Chemoradiotherapy, Adjuvant/standards
- Esophageal Neoplasms/mortality/pathology/surgery/therapy
- Esophagectomy
- Esophagus/pathology
- Female
- Fibrosis
- Follow-Up Studies
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Multivariate Analysis
- Neoadjuvant Therapy/standards
- Neoplasm Grading
- Neoplasm Invasiveness
- Neoplasm, Residual
- Prognosis
- Proportional Hazards Models
- Retrospective Studies
- Survival Rate
- Treatment Outcome
Affiliation
Research group
Citation (ISO format)
PUETZ, Katharina et al. Neoadjuvant chemoradiation for patients with advanced oesophageal cancer - which response grading system best impacts prognostic discrimination? In: Histopathology, 2019, vol. 74, n° 5, p. 731–743. doi: 10.1111/his.13811
Main files (1)
Article (Published version)

Identifiers
- PID : unige:146959
- DOI : 10.1111/his.13811
- PMID : 30636069
ISSN of the journal0309-0167